Differential diagnostics of pelvic actinomycosis with advanced gynaecological cancer

Cover Page


Cite item

Full Text

Abstract

Objective: Actinomycosis is filamentous gram-positive anaerobic bacterium. Clinically, actinomycosis can mimic malignancy. The differential diagnosis with carcinoma is difficult. The aim of our exploration is definition of history's clinical pathological and biological analyses' significance.

Full Text

Objective: Actinomycosis is filamentous gram-positive anaerobic bacterium. Clinically, actinomycosis can mimic malignancy. The differential diagnosis with carcinoma is difficult. The aim of our exploration is definition of history's clinical pathological and biological analyses' significance.

Methods: We analyzed all the records of 9 women (mean 43,2 years). 4 of then had intrauterine devices (IUD) for the previous 4-8 years. All patients presented leukocytosis, fever, anemia. The clinical examination showed a palpable hypogastric mass. Ultrasound and computed tomography showed an unilateral or bilateral large masse arising from adnexum, adherent to the uterus and compressing the urinary bladder with peritoneal carcinomatosis.

Results: A preoperative diagnosis of advanced ovarian cancer was made. Laparotomy reveled a large inflammatory mass involving uterus, adnexa and other pelvic structures. Bilateral salpingoophorectomy and total abdominal hysterectomy were performed. After pathological analyses, actinomycosis was diagnosed (was detected specific actinomycotic granuloma). All patients were treated postoperatively with ampicillin.

Conclusions: Pelvic actinomycosis is a rare inflammation which clinically and radiologically can successfully mimic ovarian cancer. Differential diagnosis is difficult but some symptoms such as leukocytosis, fever, history of IUD use, absence of serum tumor markers, typical inflammatory appearance during surgery should prompt a diagnosis of actinomycosis. An intraoperative frozen section should be obligatory for all patients. Culture methods of diagnosis, Gram-Veigert staining, hematoxylin staining should be used followed by histological verification.

×

About the authors

E. V. Bakhidze

Prof. N.N. Petrov Institute of Oncology; Institute of Medical Micology

Author for correspondence.
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg

A. F. Ourmantcheeva

Prof. N.N. Petrov Institute of Oncology; Institute of Medical Micology

Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg

A. K. Mirzabalayeva

Prof. N.N. Petrov Institute of Oncology; Institute of Medical Micology

Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg

Ju. V. Dolgo-Saburova

Prof. N.N. Petrov Institute of Oncology; Institute of Medical Micology

Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg

N. G. Shashkova

Prof. N.N. Petrov Institute of Oncology; Institute of Medical Micology

Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 1999 Eсо-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 66759 от 08.08.2016 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия Эл № 77 - 6389
от 15.07.2002 г.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies